Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

SUCCESSFUL TREATMENT FREE REMISSION IN CML AFTER 2 YEAR CONSOLIDATION WITH NILOTINIB OF AN MR4.5 RESPONSE LEVEL ACHIEVED ORIGINALLY WITH IMATINIB TREATMENT: FIRST REPORT FROM STAT2 TRIAL IN JAPAN

N. Takahashi,K. Nishiwaki,C. Nakaseko,H. Wakita, K. Sano,C. Ohwada,N. Aotsuka,J. Kuroki,H. Kimura,H. Noji,M. Tokuhira, K. Mitani,K. Fujikawa,O. Iwase,K. Ohishi, F. Kimura,T. Fukuda, S. Tanosaki,M. Miura,K. Sawada

HAEMATOLOGICA（2016）

Cited 0|Views2
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined